Alentis Therapeutics
Alentis Therapeutics discovers and develops novel medications to treat advanced liver diseases.
Alentis Therapeutics has raised €11M across 1 funding round from 2 investors, most recently a Series A round in Apr 2019. Based in Basel, Switzerland; active in Healthtech. Data as of 28 Oct 2026.
Basel, Switzerlandalentis.ch ↗
Total raised
€11M
€11,179,680
Funding rounds
1
Investors
2
distinct backers
Active since
2019-04
latest 2019-04
Funding by year
EUR raised per yearAlentis Therapeutics — funding by year — interactive chart.
Data table
| Alentis Therapeutics — funding by year | |
|---|---|
| 2019 | €11M |
Signals
High confidenceRaise-next likelihood8
base rate 44% for Series A
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2019-04-01 | Series A | €11M | BioMedPartners,Pureos Bioventures | View deal → |
Investors
2Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Neko Health€924MSweden · Healthtech
- Climeworks€919MSwitzerland · Cleantech
Global coverage: FundingData